These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19156339)

  • 1. [Andrological testosterone replacement therapy].
    Paasch U; Glander HJ; Stolzenburg JU
    Urologe A; 2009 Jan; 48(1):79-86; quiz 87. PubMed ID: 19156339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Testosterone replacement: application and surveillance].
    Popken G
    Urologe A; 2010 Jan; 49(1):37-42. PubMed ID: 20111920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of testosterone replacement therapy on lower urinary tract symptoms: A systematic review and network meta-analysis.
    Yuan X; Xiong X; Xue J
    J Evid Based Med; 2024 Sep; 17(3):490-502. PubMed ID: 39004879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of polycythaemia induced by intramuscular androgen replacement using transdermal testosterone therapy.
    Siddique H; Smith JC; Corrall RJ
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):143-5. PubMed ID: 14678301
    [No Abstract]   [Full Text] [Related]  

  • 5. [Testosterone and the prostate].
    Sperling H; Rossi R; Lümmen G; Rübben H
    Urologe A; 2004 Sep; 43(9):1092-6. PubMed ID: 15368045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New modalities of transdermal testosterone replacement.
    Basaria S; Dobs AS
    Treat Endocrinol; 2003; 2(1):1-9. PubMed ID: 15871550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
    Afiadata A; Ellsworth P
    Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Testosterone replacement therapy and prostate cancer: the downfall of a paradigm?].
    Castillo OA; López-Fontana G; Vidal-Mora I; López Laur JD
    Medwave; 2015 Apr; 15(3):e6115. PubMed ID: 25919660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypotestosteronaemia in the aging male: should we treat it?
    Christe N; Meier CA
    Swiss Med Wkly; 2015; 145():w14216. PubMed ID: 26599486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The uses and misuses of testosterone therapy.
    Johns Hopkins Med Lett Health After 50; 2006 Aug; 18(6):3, 7. PubMed ID: 16921650
    [No Abstract]   [Full Text] [Related]  

  • 11. [Testosterone therapy].
    Diemer T; Hauptmann A; Wagenlehner FM
    Urologe A; 2016 Apr; 55(4):539-48; quiz 549-50. PubMed ID: 27067659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Overview of Testosterone Therapy.
    Lee OD; Tillman K
    Am J Mens Health; 2016 Jan; 10(1):68-72. PubMed ID: 25398416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events during testosterone replacement therapy in 95 young hypogonadal thalassemic men.
    De Sanctis V; Soliman AT; Daar S; Di Maio S
    Acta Biomed; 2019 May; 90(2):228-232. PubMed ID: 31125000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone therapy: many players and much controversy.
    Sigman M
    Fertil Steril; 2015 May; 103(5):1144-5. PubMed ID: 25934600
    [No Abstract]   [Full Text] [Related]  

  • 15. Testosterone supplementation does not worsen lower urinary tract symptoms.
    Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
    J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Testosterone substitution in aging males. Which questions are answered?].
    Krause W
    Urologe A; 2004 Sep; 43(9):1097-100. PubMed ID: 15368046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations.
    Yeap BB; Grossmann M; McLachlan RI; Handelsman DJ; Wittert GA; Conway AJ; Stuckey BG; Lording DW; Allan CA; Zajac JD; Burger HG
    Med J Aust; 2016 Sep; 205(5):228-31. PubMed ID: 27581270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks of testosterone-replacement therapy and recommendations for monitoring.
    Rhoden EL; Morgentaler A
    N Engl J Med; 2004 Jan; 350(5):482-92. PubMed ID: 14749457
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study.
    Legros JJ; Meuleman EJ; Elbers JM; Geurts TB; Kaspers MJ; Bouloux PM;
    Eur J Endocrinol; 2009 May; 160(5):821-31. PubMed ID: 19211706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
    Miner MM; Seftel AD
    Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.